CTRI/2009/091/000154Other2 期
A Phase 2a, Multicentre, Double Blind , Randomized , Active controlled , Parallel arm clinical study to study the Efficacy and Safety of Mk-0941 Compared to sulphonylureas in Patients with Type 2 Diabetes Mellitus With Inadequate Glycemic control on Metformin therapy.
Merck Sharp and Dohme0 个研究点目标入组 130 人开始时间: 待定最近更新:
试验速览
- 阶段
- 2 期
- 状态
- Other
- 发起方
- 入组人数
- 130
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
入选标准
- •Patient has type 2 diabetes mellitus
- •Between the ages of 18 and 70
排除标准
- •Patient has a history of type 1 Diabetes Mellitus or ketoacidosis.
- •Patient is on a weight loss program and is not in the maintenance phase or is taking weight loss medication.
- •Patient has had surgery within 30 days of starting the study or has planned major surgery during the study
研究者
相似试验
进行中（未招募）
1 期
A Phase 2a Multicenter, Randomized, Double Blind, Parallel, Proof of concept Study Evaluating the Efficacy and Safety of Nipocalimab and Certolizumab Combination Therapy in Participants with Active Rheumatoid Arthritis despite Prior Treatment with Advanced Therapies (bDMARD or tsDMARD)Rheumatoid ArthritisCTIS2023-504045-31-00Janssen - Cilag International85
进行中（未招募）
1 期
A study of PQ912 in patients with Alzheimer's Disease.Early Stage Alzheimer's DiseaseMedDRA version: 19.0Level: LLTClassification code 10001896Term: Alzheimer's diseaseSystem Organ Class: 10029205 - Nervous system disordersMedDRA version: 19.0Level: PTClassification code 10074616Term: Prodromal Alzheimer's diseaseSystem Organ Class: 10029205 - Nervous system disordersEUCTR2014-001967-11-NLProbiodrug AG110
进行中（未招募）
1 期
A study of PQ912 in patients with Alzheimer's Disease.Early Stage Alzheimer's DiseaseMedDRA version: 18.1Level: LLTClassification code 10001896Term: Alzheimer's diseaseSystem Organ Class: 10029205 - Nervous system disordersMedDRA version: 18.1Level: PTClassification code 10074616Term: Prodromal Alzheimer's diseaseSystem Organ Class: 10029205 - Nervous system disordersEUCTR2014-001967-11-SEProbiodrug AG110
进行中（未招募）
1 期
A study of PQ912 in patients with Alzheimer's Disease.Early Stage Alzheimer's DiseaseMedDRA version: 19.0Level: LLTClassification code 10001896Term: Alzheimer's diseaseSystem Organ Class: 10029205 - Nervous system disordersMedDRA version: 19.0Level: PTClassification code 10074616Term: Prodromal Alzheimer's diseaseSystem Organ Class: 10029205 - Nervous system disordersEUCTR2014-001967-11-DEProbiodrug AG110
已完成
2 期
A Phase 2A Multicenter, Randomized, Double Blind, Placebo-Controlled, Parallel-Group Safety and Tolerability Trial of PQ912 in Subjects with early Alzheimer's DiseaseAlzheimer's disease10057167DementiaNL-OMON44623Probiodrug AG10